Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Megarounds for Tune, Umoja

Though most of January’s VC news came out ahead of the industry’s largest conference, a handful of biotechs announced fundings this week

By Gunjan Ohri, Data Content Analyst, and Paul Bonanos, Director of Biopharma Intelligence
January 16, 2025 8:44 PM UTC

Venture fundings slowed a bit during the week of the J.P. Morgan Healthcare Conference, as most private biotechs with fresh cash chose to announce their rounds ahead of anticipated news flow around de...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Be Biopharma Inc.

Bioptimus S.A.S.

Immunis Inc.

Normunity Inc.

Owlstone Medical Ltd.

Tethis S.p.A.

Tune Therapeutics Inc.